NCT00821561View on ClinicalTrials.gov

A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects

PHASE2WithdrawnINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

March 31, 2010

Conditions
Persistent Epithelial Defect
Interventions
DRUG

Nexagon®

DRUG

Nexagon® vehicle

Sponsors
All Listed Sponsors
lead

OcuNexus Therapeutics, Inc.

INDUSTRY